Business Context and Reporting Period
This Form 8-K Current Report was filed by Abbott Laboratories on March 15, 2002. The filing addresses a significant corporate governance event: the replacement of the company's independent public accounting firm.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly procedural regarding the change in auditors and does not contain financial statement data.
Material Changes
- Change in Auditor: On March 15, 2002, the Board of Directors adopted the Audit Committee's recommendation to replace Arthur Andersen LLP as the company's auditors.
- Successor Status: As of the filing date, a new independent public accounting firm had not yet been engaged.
- Audit History: Arthur Andersen's reports for the years ended December 31, 2001, and 2000, did not contain adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
- Disagreements: There were no disagreements with Arthur Andersen on accounting principles, practices, financial statement disclosures, or auditing scope/procedures during the reported periods.
Outlook, Risks, and Management Commentary
Management confirmed that there were no "reportable events" as defined in Item 304(a)(1)(v) of Regulation S-K. Arthur Andersen LLP provided a letter dated March 21, 2002, agreeing with the statements made by Abbott regarding the lack of disagreements and the nature of their past audit reports. No specific forward-looking guidance or new risk factors were disclosed in this document.
Key Facts for Investor Verification
- Verify the identity and engagement date of the new independent public accounting firm.
- Confirm the status of the 2001 and 2002 audit processes following the departure of Arthur Andersen.
- Review subsequent filings for any restatements or qualifications related to the periods audited by the former firm.